WO2002058681A3 - Utilisation d'une rhéine pour la préparation d'un médicament pour le traitement d'un taux élevé d'il-1. - Google Patents
Utilisation d'une rhéine pour la préparation d'un médicament pour le traitement d'un taux élevé d'il-1. Download PDFInfo
- Publication number
- WO2002058681A3 WO2002058681A3 PCT/FR2002/000271 FR0200271W WO02058681A3 WO 2002058681 A3 WO2002058681 A3 WO 2002058681A3 FR 0200271 W FR0200271 W FR 0200271W WO 02058681 A3 WO02058681 A3 WO 02058681A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rhein
- treating
- medicine
- preparing
- high level
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02712018A EP1363613A2 (fr) | 2001-01-23 | 2002-01-23 | Utilisation d'une rheine pour la preparation d'un medicament pour le traitement d'un taux eleve d'il-1. |
MXPA03006596A MXPA03006596A (es) | 2001-01-23 | 2002-01-23 | Uso de una reina para preparacion de un medicamento para el tratamiento de un nivel elevado de il-1. |
IL15695702A IL156957A0 (en) | 2001-01-23 | 2002-01-23 | Use of rhein for preparing a medicine for treating a high level of il-1 |
CA002434052A CA2434052A1 (fr) | 2001-01-23 | 2002-01-23 | Utilisation d'une rheine pour la preparation d'un medicament pour le traitement d'un taux eleve d'il-1 |
AU2002231927A AU2002231927A1 (en) | 2001-01-23 | 2002-01-23 | Use of rhein for preparing a medicine for treating a high level of il-1 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/768,816 US20020128317A1 (en) | 2001-01-23 | 2001-01-23 | Treatment of pathological conditions characterized by an increased IL-1 level |
US09/768,816 | 2001-01-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002058681A2 WO2002058681A2 (fr) | 2002-08-01 |
WO2002058681A3 true WO2002058681A3 (fr) | 2002-12-19 |
WO2002058681A8 WO2002058681A8 (fr) | 2003-03-06 |
Family
ID=25083563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2002/000271 WO2002058681A2 (fr) | 2001-01-23 | 2002-01-23 | Utilisation d'une rhéine pour la préparation d'un médicament pour le traitement d'un taux élevé d'il-1. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20020128317A1 (fr) |
EP (1) | EP1363613A2 (fr) |
AU (1) | AU2002231927A1 (fr) |
CA (1) | CA2434052A1 (fr) |
IL (1) | IL156957A0 (fr) |
MX (1) | MXPA03006596A (fr) |
WO (1) | WO2002058681A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797727B2 (en) | 2001-07-16 | 2004-09-28 | Transition Therapeutics Inc. | Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases |
FR2842738B1 (fr) * | 2002-07-23 | 2006-02-10 | Negma Lerads | Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus |
CN1314361C (zh) * | 2003-04-02 | 2007-05-09 | 李安虎 | 一种关节保健饮品或食品及其制备方法 |
MXPA04009698A (es) * | 2004-10-04 | 2006-04-05 | Maria Elena Garcia Armenta | Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam. |
WO2009034409A2 (fr) * | 2007-09-14 | 2009-03-19 | Wockhardt Research Centre | Compositions pharmaceutiques de rheine ou de diacereine |
FR2920991A1 (fr) * | 2007-09-14 | 2009-03-20 | Wockhardt Ltd | Composition a base de diacerheine pour le traitement de l'arthrose |
EP2060562A1 (fr) * | 2007-11-16 | 2009-05-20 | Laboratoire Medidom S.A. | Dérivés de sulfonate de dioxoanthracène |
US9119819B2 (en) * | 2008-04-30 | 2015-09-01 | Wockhardt Ltd. | Oral liquid compositions of rhein or diacerein |
EP3337782A4 (fr) * | 2015-08-17 | 2019-04-03 | TWI Biotechnology, Inc. | Diacéréine ou ses analogues pour inhibition de l'expression des protéines asc et nlrp3, et/ou de la formation du complexe de l'inflammasome nlrp3 |
TW201739448A (zh) * | 2016-05-06 | 2017-11-16 | 安成生物科技股份有限公司 | 用於治療及/或預防血液相關疾病之方法及配方 |
BR112019014761A2 (pt) * | 2017-01-18 | 2020-03-03 | Tairx, Inc. | Composições para uso no tratamento de doenças inflamatórias do intestino e da colite intestinal |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0698594A1 (fr) * | 1994-08-24 | 1996-02-28 | Lilly Industries Limited | Dérivés pharmaceutiques d'anthraquinone |
EP0822178A1 (fr) * | 1996-07-31 | 1998-02-04 | Laboratoire Medidom S.A. | Dérivés de la rhéine et procédés pour produire des dérivés de la rhéine |
JPH10114650A (ja) * | 1996-10-15 | 1998-05-06 | Dokutaazu Kosumeteikusu:Kk | 津液改善剤及びそれを含有する経口投与用組成物 |
JPH10120556A (ja) * | 1996-10-18 | 1998-05-12 | Dokutaazu Kosumeteikusu:Kk | 津液改善用皮膚外用剤 |
US5952383A (en) * | 1996-07-04 | 1999-09-14 | Negma-Steba International Development N.V. | Pharmaceutical composition for oral delivery |
US6124358A (en) * | 1996-12-23 | 2000-09-26 | Mazal Pharmaceutique (Sarl) | Pharmaceutical composition containing rhein or diacerhein with improved bioavailability |
WO2001051044A2 (fr) * | 2000-01-12 | 2001-07-19 | Laboratoire Medidom S.A. | Substances utilisees dans le traitement du psoriasis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA761627B (en) * | 1976-03-16 | 1978-01-25 | C Friedmann | Improvements in or relating to the treatment of arthritis |
IT1283772B1 (it) * | 1996-07-31 | 1998-04-30 | Medidom Lab | Procedimento per la preparazione di reina e diacereina |
-
2001
- 2001-01-23 US US09/768,816 patent/US20020128317A1/en not_active Abandoned
-
2002
- 2002-01-23 WO PCT/FR2002/000271 patent/WO2002058681A2/fr not_active Application Discontinuation
- 2002-01-23 CA CA002434052A patent/CA2434052A1/fr not_active Abandoned
- 2002-01-23 EP EP02712018A patent/EP1363613A2/fr not_active Withdrawn
- 2002-01-23 IL IL15695702A patent/IL156957A0/xx unknown
- 2002-01-23 AU AU2002231927A patent/AU2002231927A1/en not_active Abandoned
- 2002-01-23 MX MXPA03006596A patent/MXPA03006596A/es not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0698594A1 (fr) * | 1994-08-24 | 1996-02-28 | Lilly Industries Limited | Dérivés pharmaceutiques d'anthraquinone |
US5952383A (en) * | 1996-07-04 | 1999-09-14 | Negma-Steba International Development N.V. | Pharmaceutical composition for oral delivery |
EP0822178A1 (fr) * | 1996-07-31 | 1998-02-04 | Laboratoire Medidom S.A. | Dérivés de la rhéine et procédés pour produire des dérivés de la rhéine |
JPH10114650A (ja) * | 1996-10-15 | 1998-05-06 | Dokutaazu Kosumeteikusu:Kk | 津液改善剤及びそれを含有する経口投与用組成物 |
JPH10120556A (ja) * | 1996-10-18 | 1998-05-12 | Dokutaazu Kosumeteikusu:Kk | 津液改善用皮膚外用剤 |
US6124358A (en) * | 1996-12-23 | 2000-09-26 | Mazal Pharmaceutique (Sarl) | Pharmaceutical composition containing rhein or diacerhein with improved bioavailability |
WO2001051044A2 (fr) * | 2000-01-12 | 2001-07-19 | Laboratoire Medidom S.A. | Substances utilisees dans le traitement du psoriasis |
Non-Patent Citations (1)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 10 31 August 1998 (1998-08-31) * |
Also Published As
Publication number | Publication date |
---|---|
WO2002058681A2 (fr) | 2002-08-01 |
EP1363613A2 (fr) | 2003-11-26 |
IL156957A0 (en) | 2004-02-08 |
MXPA03006596A (es) | 2004-05-05 |
CA2434052A1 (fr) | 2002-08-01 |
AU2002231927A1 (en) | 2002-08-06 |
US20020128317A1 (en) | 2002-09-12 |
WO2002058681A8 (fr) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0128108D0 (en) | Therapeutic use | |
WO2002058681A3 (fr) | Utilisation d'une rhéine pour la préparation d'un médicament pour le traitement d'un taux élevé d'il-1. | |
HK1096859A1 (en) | Methods for treating interleukin-6 related diseases | |
EP1600169A3 (fr) | Dérivé de pyrrolidine acetamide, seul ou en combinaison, pour le traitement des maladies du système nerveux central | |
WO2003014309A3 (fr) | Recepteurs de l'interleukine-1 dans le traitement de maladies | |
PL367277A1 (en) | Methods of making sustained release formulations of oxymorphone related applications | |
EP2298812A3 (fr) | Remèdes pour maladies associées à l'arthrite chronique chez l'enfant | |
DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
AU2003239531A1 (en) | Protein cages for the delivery of medical imaging and therapy | |
NO983543D0 (no) | Preparat omfattende interleukin-1-inhibitor og polymer med regulert frigivelse | |
SE9800836D0 (sv) | New Compounds | |
NZ530950A (en) | 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases | |
ZA200306171B (en) | (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes. | |
WO2005018605A3 (fr) | Nouvelle formulation | |
WO1999054460A3 (fr) | Sequences d'acide nucleique provenant du tissu normal de la vessie | |
WO1999054447A3 (fr) | Sequences d'acide nucleique provenant de tissus tumoraux de la vessie | |
AU2002322263A1 (en) | Eglin c based drugs for treatment of disease | |
DE69819922D1 (de) | 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten | |
HUP0202741A2 (hu) | Méhen kívüli méhnyálkahártya-növekedés, krónikus medencefájdalom és petevezeték-elzáródás gyógyászati kezelésére alkalmas gyógyszerkészítmény és eljárás az előállítására | |
MXPA04001805A (es) | Nueva forma de dosificacion oral de liberacion prolongada. | |
ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
WO1996041607A3 (fr) | Compositions parmaceutiques comprenant de la restrictine p/activine a, et leur utilisation en qualite d'antagonistes de il-6 et/ou il-11 | |
SE9904424D0 (sv) | Use of interleukin-6 in combination with leptin in treatment of obesity | |
AU2002224253A1 (en) | Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases | |
HUP0202416A2 (hu) | Új kombinációs gyógyszerkészítmény és ennek alkalmazása kardiovaszkuláris rendellenességek kezelésében |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG BR CA CN CZ DZ HU ID IL IN JP KR LT LV MA MX NO NZ PL RO RU SG SI SK TR US VN ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG BR CA CN CZ DZ HU ID IL IN JP KR LT LV MA MX NO NZ PL RO RU SG SI SK TR US VN ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AU BG BR CA CN CZ DZ HU ID IL IN JP KR LT LV MA MX NO NZ PL RO RU SG SI SK TR US VN ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE IN ENGLISH REPLACED BY CORRECT TITLE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002712018 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2434052 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 156957 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/006596 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2002712018 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002712018 Country of ref document: EP |